Stephane Berghmans
Nessuna posizione attualmente
Profilo
Stephane Berghmans worked as the Director of Drug Discovery at Znomics, Inc. and as the Head of Safety Pharmacology at Summit Therapeutics Ltd.
from 2004 to 2008.
He received a doctorate degree from the University of Liege in 2000 and another doctorate degree from the same university in 1994.
He also received an undergraduate degree from the Université Catholique de Louvain.
Precedenti posizioni note di Stephane Berghmans
| Società | Posizione | Fine |
|---|---|---|
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Corporate Officer/Principal | 01/01/2008 |
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Formazione di Stephane Berghmans
| Université Catholique de Louvain | Undergraduate Degree |
| University of Liege | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Znomics, Inc.
Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | Finance |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Stephane Berghmans
